<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Pathog</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Pathog</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plospath</journal-id><journal-title-group><journal-title>PLoS Pathogens</journal-title></journal-title-group><issn pub-type="ppub">1553-7366</issn><issn pub-type="epub">1553-7374</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6171941</article-id><article-id pub-id-type="doi">10.1371/journal.ppat.1007019</article-id><article-id pub-id-type="publisher-id">PPATHOGENS-D-18-00388</article-id><article-categories><subj-group subj-group-type="heading"><subject>Opinion</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>DNA viruses</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Vaccinia Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Vaccinia Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Vaccinia Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Vaccinia Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>Vector cloning</subject><subj-group><subject>YAC cloning</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>Vector cloning</subject><subj-group><subject>YAC cloning</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>DNA viruses</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Smallpox Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Smallpox Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Smallpox Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject><subj-group><subject>Smallpox Virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Synthetic Biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Engineering and Technology</subject><subj-group><subject>Synthetic Biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>DNA cloning</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>DNA cloning</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>DNA viruses</subject><subj-group><subject>Poxviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical Microbiology</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial Pathogens</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral Pathogens</subject><subj-group><subject>Poxviruses</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Molecular biology</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>Vector cloning</subject><subj-group><subject>BAC cloning</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Molecular biology techniques</subject><subj-group><subject>Cloning</subject><subj-group><subject>Vector cloning</subject><subj-group><subject>BAC cloning</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Synthetic viruses&#x02014;Anything new?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5783-0887</contrib-id><name><surname>Thiel</surname><given-names>Volker</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Infectious Diseases and Pathobiology, University of Bern, Bern, Switzerland</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Federal Department of Home Affairs, Institute of Virology and Immunology, Bern and Mittelh&#x000e4;usern, Switzerland</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Coyne</surname><given-names>Carolyn B.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of Pittsburgh, UNITED STATES</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The author is Associate Editor of PLOS ONE and has handled the manuscript "Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments" by Noyce et al. The author is a member of the Swiss Expert Committee for Biosafety (SECB), a permanent federal advisory committee that advises the Federal Council and the federal agencies on the drafting of laws, ordinances, guidelines, and recommendations. This does not alter my adherence to all PLOS policies on sharing data and materials.</p></fn><corresp id="cor001">* E-mail: <email>Volker.thiel@vetsuisse.unibe.ch</email></corresp></author-notes><pub-date pub-type="epub"><day>4</day><month>10</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2018</year></pub-date><volume>14</volume><issue>10</issue><elocation-id>e1007019</elocation-id><permissions><copyright-statement>&#x000a9; 2018 Volker Thiel</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Volker Thiel</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="ppat.1007019.pdf"/><related-article id="d35e452" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.ppat.1007025">
<article-title>Synthetic horsepox viruses and the continuing debate about dual use research</article-title>
</related-article><related-article id="d35e457" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.ppat.1007129">
<article-title>Horsepox and the need for a new norm, more transparency, and stronger oversight for experiments that pose pandemic risks</article-title>
</related-article><related-article id="d35e462" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.ppat.1007286">
<article-title>Inoculating science against potential pandemics and information hazards</article-title>
</related-article><related-article id="d35e467" related-article-type="companion" ext-link-type="doi" xlink:href="10.1371/journal.ppat.1007344">
<article-title>Horsepox: Framing A Dual Use Research of Concern Debate</article-title>
</related-article><funding-group><funding-statement>The author's lab is supported by the Swiss National Science Foundation (SNF grants #310030_173085, CRSII3_160780,320030E-165076) and the European Commission (Marie Sklodowska-Curie Innovative Training Network; grant agreement No 721367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="0"/><page-count count="5"/></counts></article-meta></front><body><sec id="sec001"><title>Synthetic horsepox virus raises concerns</title><p>The report of the construction of an infectious horsepox virus from synthesized DNA by Noyce, Lederman, and Evans [<xref rid="ppat.1007019.ref001" ref-type="bibr">1</xref>] raised considerable concerns about whether this study will facilitate the construction of smallpox virus (variola) using synthetic biology [<xref rid="ppat.1007019.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="ppat.1007019.ref005" ref-type="bibr">5</xref>]. This is a valid concern, but for a number of reasons&#x02014;as explained below&#x02014;no major change concerning the likelihood of a &#x0201c;resurrection&#x0201d; of smallpox emerges from this publication. Having said this, it is also evident that the scientific community, politicians, decision makers, and the lay public have to continue, and probably intensify, a discussion on benefits and risks of synthetic biology in a broader sense.</p></sec><sec id="sec002"><title>What has been done?</title><p>The study &#x0201c;Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments&#x0201d; was conducted in the laboratory of Dr. Evans, University of Alberta, Canada. The authors describe a workflow from chemically synthesized DNA to the rescue of infectious horsepox virus with the intention to generate a horsepox virus&#x02013;based vaccine that may be equally as efficacious as vaccinia virus&#x02013;based vaccines but may have less severe side effects. Since the introduction of vaccinia virus as a vaccine against smallpox by Edward Jenner more than 200 years ago, the origin and passage history of this vaccine have remained elusive. However, recent sequencing data revealed close similarities between horsepox and vaccinia viruses, suggesting that horsepox virus might serve as a candidate smallpox vaccine [<xref rid="ppat.1007019.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="ppat.1007019.ref008" ref-type="bibr">8</xref>]. There is just one problem: there have been no horsepox virus infections reported since the 1980s, and the virus might actually be extinct [<xref rid="ppat.1007019.ref009" ref-type="bibr">9</xref>]. Therefore, Evans and colleagues set out to &#x0201c;resurrect&#x0201d; horsepox virus from synthesized DNA. To achieve this, they made use of (i) the ability of poxviruses to facilitate homologous recombination, (ii) a helpervirus (Shope fibroma virus) to launch poxvirus replication from naked DNA [<xref rid="ppat.1007019.ref010" ref-type="bibr">10</xref>], and (iii) recent advances in synthetic biology, namely, the ability to chemically synthesize large DNA fragments.</p></sec><sec id="sec003"><title>Anything new?</title><p>The authors are now blamed for providing a workflow that allows for the generation of any infectious poxvirus, including smallpox virus, from synthesized DNA (<xref ref-type="fig" rid="ppat.1007019.g001">Fig 1</xref>). But is this actually new? According to the PLOS Dual Use Research of Concern (DURC) Committee, &#x0201c;The study did not provide new information specifically enabling the creation of a smallpox virus, but uses known methods, reagents and knowledge that have previously been used in the synthesis of other viruses (such as influenza and polio viruses)&#x0201d; [<xref rid="ppat.1007019.ref005" ref-type="bibr">5</xref>]. Indeed, the individual experimental steps and methods to generate infectious horsepox virus have been reported before.</p><fig id="ppat.1007019.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.ppat.1007019.g001</object-id><label>Fig 1</label><caption><title>Cloning of synthetic DNA.</title><p>The generation of synthetic poxviruses as described by Evans and colleagues and cloning of synthetic DNA using TAR in yeast are illustrated. Synthesized DNA fragments are assembled and cloned in a set of plasmids containing overlapping DNA fragments. Release of cloned DNA fragments from plasmids creates a set of overlapping DNA fragments that can recombine in yeast (TAR cloning) to form a YAC/BAC (left side) or in helpervirus-infected cells to rescue poxviruses (right side). The yeast hub is versatile and allows for the generation of synthetic viruses, bacteria, and even eukaryotic chromosomes. BAC, bacterial artificial chromosome; TAR, transformation-associated recombination; YAC, yeast artificial chromosome.</p></caption><graphic xlink:href="ppat.1007019.g001"/></fig><p>First, it has long been known that poxviruses can mediate homologous recombination, and this has been used for decades to modify mainly vaccinia virus, but also other poxviruses. It is therefore not surprising that overlapping DNA fragments are joined in poxvirus-infected cells by homologous recombination [<xref rid="ppat.1007019.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="ppat.1007019.ref012" ref-type="bibr">12</xref>].</p><p>Second, procedures to rescue poxviruses from naked DNA have also been established for decades [<xref rid="ppat.1007019.ref013" ref-type="bibr">13</xref>, <xref rid="ppat.1007019.ref014" ref-type="bibr">14</xref>]. Helperviruses, such as fowlpox virus, are routinely used to launch replication from naked vaccinia virus genomic DNA. This procedure has been successfully used to generate recombinant vaccinia viruses containing insertions of up to 26&#x02013;31 kbp of foreign DNA [<xref rid="ppat.1007019.ref015" ref-type="bibr">15</xref>, <xref rid="ppat.1007019.ref016" ref-type="bibr">16</xref>]. Moreover, fowlpox virus has also been used as a helpervirus to launch vaccinia virus replication from a full-length vaccinia virus DNA cloned as a bacterial artificial chromosome (BAC) in <italic>Escherichia coli</italic> [<xref rid="ppat.1007019.ref017" ref-type="bibr">17</xref>]. This work by Domi and Moss is remarkable because it demonstrated for the first time that infectious vaccinia virus has been obtained from cloned circular DNA as opposed to previous techniques that required a linear vaccinia virus genome with authentic genome ends.</p><p>Third, it comes as no surprise that it is possible to generate infectious viruses by using synthesized DNA fragments [<xref rid="ppat.1007019.ref018" ref-type="bibr">18</xref>]. The first synthetic virus, poliovirus, was produced by Wimmer and colleagues and made us aware of the fact that we entered a new era of reverse genetics that allows for the generation of synthetic viruses without the need for a nucleic acid template [<xref rid="ppat.1007019.ref019" ref-type="bibr">19</xref>]. This is instrumental to generate infectious viruses for which no isolates are available. The 1918 &#x0201c;Spanish&#x0201d; influenza virus is the first example of a &#x0201c;resurrected&#x0201d; virus that was constructed by only knowing the genome sequence [<xref rid="ppat.1007019.ref020" ref-type="bibr">20</xref>]. Also, more complex and larger RNA viruses, such as coronaviruses (up to 30 kb genome size), can be synthesized, as demonstrated by Denison and colleagues for a Severe Acute Respiratory Syndrome (SARS)-like virus [<xref rid="ppat.1007019.ref021" ref-type="bibr">21</xref>]&#x02014;a virus that was sequenced from bat samples and represents the likely origin of the SARS coronavirus that caused an epidemic starting in China in 2002.</p></sec><sec id="sec004"><title>Synthetic biology&#x02014;Quo vadis?</title><p>The synthesis of infectious horsepox virus by Evans and colleagues demonstrates that synthetic biology has entered the field of large DNA viruses. Although the procedure to generate synthetic horsepox virus by Evans is quite specific for poxviruses, very general and widely applicable procedures to assemble and clone large DNA fragments using transformation-associated recombination (TAR) in yeast (<italic>Sacharomyces cerevisae</italic>) have been established. By using overlapping synthetic DNA fragments, TAR cloning, and yeast as a hub, it was possible to clone full-length herpesvirus genomes (human cytomegalovirus [hCMV] and herpes simplex virus 1 [HSV1]) as yeast artificial chromosomes (YACs) [<xref rid="ppat.1007019.ref022" ref-type="bibr">22</xref>, <xref rid="ppat.1007019.ref023" ref-type="bibr">23</xref>]. The YACs have been transferred into <italic>E</italic>. <italic>coli</italic> for DNA amplification in the form of a BAC, and synthetic hCMV and HSV1 were rescued following transfection into appropriate mammalian cells. This procedure is versatile (<xref ref-type="fig" rid="ppat.1007019.g001">Fig 1</xref>), and it is equally applicable to assemble and clone poxvirus genomes. Moreover, a YAC/BAC carrying a poxvirus genome can be used to launch replication of infectious poxviruses as described by Domi and Moss [<xref rid="ppat.1007019.ref017" ref-type="bibr">17</xref>].</p><p>These examples illustrate the fact that synthetic biology has matured towards a powerful technique that will impact the scientific community&#x02014;and our society in general&#x02014;similar to the advent of recombinant DNA technology in the 1970s. It is already possible to generate synthetic bacteria [<xref rid="ppat.1007019.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="ppat.1007019.ref026" ref-type="bibr">26</xref>] and eukaryotic chromosomes [<xref rid="ppat.1007019.ref027" ref-type="bibr">27</xref>&#x02013;<xref rid="ppat.1007019.ref034" ref-type="bibr">34</xref>], and it can be expected that synthetic eukaryotic cells will follow soon. Therefore, the impact of synthetic biology goes far beyond the question of DURC, as in the case of viruses, and we have to find a way to cope with the fact that this technology will allow the generation of designer microbes and, ultimately, synthetic life.</p><p>In Switzerland, a discussion has been initiated by the Swiss Academy of Sciences that developed as a result of workshops with life scientists from Swiss academic institutions on ways of addressing the misuse potential of biological research [<xref rid="ppat.1007019.ref035" ref-type="bibr">35</xref>]. Similar initiatives in which benefits and risks of DURC can be openly discussed have been launched in many countries and are needed to raise awareness within the scientific community. However, it should be noted that we have sufficient regulations in place to ensure biosafety and biosecurity. Moreover, we have already seen the benefits of synthetic viruses. The recovery of the pandemic 1918 influenza virus provided important mechanistic insight into critical determinants of virus tropism, transmission, and pathogenicity. Likewise, the recovery of the SARS-like bat coronavirus shed light on determinants of zoonotic infection. Such information is urgently needed to understand cross-species transmission of contemporary virus strains and to assess the risk of emerging pandemic viruses. Synthetic viruses also allow us to explore novel concepts to combat virus infection, such as virus attenuation by large-scale recoding, pioneered by Wimmer and colleagues [<xref rid="ppat.1007019.ref018" ref-type="bibr">18</xref>]. It is foreseeable that such concepts will greatly increase our preparedness to emerging viruses because it is now just a matter of weeks to generate synthetic viruses from genomic sequences and at the same time to synthesize attenuated candidate vaccine strains. The fast technological advances in synthetic biology illustrate that the breadth of synthetic biology goes beyond DURC, and our discussions should be well balanced to allow this novel technology to evolve. We&#x02019;re just beginning to explore the potential of synthetic biology that is expected to become a powerful tool to reveal groundbreaking insights in all fields of life sciences.</p></sec></body><back><ref-list><title>References</title><ref id="ppat.1007019.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Noyce</surname><given-names>RS</given-names></name>, <name><surname>Lederman</surname><given-names>S</given-names></name>, <name><surname>Evans</surname><given-names>DH</given-names></name>. <article-title>Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments</article-title>. <source>PLoS ONE</source>. <year>2018</year>;<volume>13</volume>(<issue>1</issue>):<fpage>e0188453</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0188453</pub-id> ; PubMed Central PMCID: PMCPMC5774680.<?supplied-pmid 29351298?><pub-id pub-id-type="pmid">29351298</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Koblentz</surname><given-names>GD</given-names></name>. <article-title>The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox</article-title>. <source>Health Secur</source>. <year>2017</year>;<volume>15</volume>(<issue>6</issue>):<fpage>620</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1089/hs.2017.0061</pub-id> .<?supplied-pmid 28836863?><pub-id pub-id-type="pmid">28836863</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Kupferschmidt</surname><given-names>K.</given-names></name>
<article-title>Critics see only risks, no benefits in horsepox paper</article-title>. <source>Science</source>. <year>2018</year>;<volume>359</volume>(<issue>6374</issue>):<fpage>375</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.359.6374.375</pub-id> .<?supplied-pmid 29371445?><pub-id pub-id-type="pmid">29371445</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Kupferschmidt</surname><given-names>K.</given-names></name>
<article-title>Labmade smallpox is possible, study shows</article-title>. <source>Science</source>. <year>2017</year>;<volume>357</volume>(<issue>6347</issue>):<fpage>115</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.357.6347.115</pub-id> .<?supplied-pmid 28706017?><pub-id pub-id-type="pmid">28706017</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref005"><label>5</label><mixed-citation publication-type="other">Group PO. Comment on &#x0201c;Construction of an infectious horsepox virus vaccine from chemically synthesized DNA fragments&#x0201d;. 2018.</mixed-citation></ref><ref id="ppat.1007019.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Medaglia</surname><given-names>ML</given-names></name>, <name><surname>Moussatche</surname><given-names>N</given-names></name>, <name><surname>Nitsche</surname><given-names>A</given-names></name>, <name><surname>Dabrowski</surname><given-names>PW</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <name><surname>Damon</surname><given-names>IK</given-names></name>, <etal>et al</etal>
<article-title>Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus</article-title>. <source>Journal of virology</source>. <year>2015</year>;<volume>89</volume>(<issue>23</issue>):<fpage>11909</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01833-15</pub-id> ; PubMed Central PMCID: PMCPMC4645304.<?supplied-pmid 26378174?><pub-id pub-id-type="pmid">26378174</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Schrick</surname><given-names>L</given-names></name>, <name><surname>Tausch</surname><given-names>SH</given-names></name>, <name><surname>Dabrowski</surname><given-names>PW</given-names></name>, <name><surname>Damaso</surname><given-names>CR</given-names></name>, <name><surname>Esparza</surname><given-names>J</given-names></name>, <name><surname>Nitsche</surname><given-names>A</given-names></name>. <article-title>An Early American Smallpox Vaccine Based on Horsepox</article-title>. <source>N Engl J Med</source>. <year>2017</year>;<volume>377</volume>(<issue>15</issue>):<fpage>1491</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMc1707600</pub-id> .<?supplied-pmid 29020595?><pub-id pub-id-type="pmid">29020595</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Tulman</surname><given-names>ER</given-names></name>, <name><surname>Delhon</surname><given-names>G</given-names></name>, <name><surname>Afonso</surname><given-names>CL</given-names></name>, <name><surname>Lu</surname><given-names>Z</given-names></name>, <name><surname>Zsak</surname><given-names>L</given-names></name>, <name><surname>Sandybaev</surname><given-names>NT</given-names></name>, <etal>et al</etal>
<article-title>Genome of horsepox virus</article-title>. <source>Journal of virology</source>. <year>2006</year>;<volume>80</volume>(<issue>18</issue>):<fpage>9244</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00945-06</pub-id> ; PubMed Central PMCID: PMCPMC1563943.<?supplied-pmid 16940536?><pub-id pub-id-type="pmid">16940536</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Esparza</surname><given-names>J.</given-names></name>
<article-title>Has horsepox become extinct?</article-title>
<source>Vet Rec</source>. <year>2013</year>;<volume>173</volume>(<issue>11</issue>):<fpage>272</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.1136/vr.f5587</pub-id> .<?supplied-pmid 24057497?><pub-id pub-id-type="pmid">24057497</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Yao</surname><given-names>XD</given-names></name>, <name><surname>Evans</surname><given-names>DH</given-names></name>. <article-title>High-frequency genetic recombination and reactivation of orthopoxviruses from DNA fragments transfected into leporipoxvirus-infected cells</article-title>. <source>Journal of virology</source>. <year>2003</year>;<volume>77</volume>(<issue>13</issue>):<fpage>7281</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.77.13.7281-7290.2003</pub-id> ; PubMed Central PMCID: PMCPMC164822.<?supplied-pmid 12805426?><pub-id pub-id-type="pmid">12805426</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Mackett</surname><given-names>M</given-names></name>, <name><surname>Smith</surname><given-names>GL</given-names></name>, <name><surname>Moss</surname><given-names>B</given-names></name>. <article-title>Vaccinia virus: a selectable eukaryotic cloning and expression vector</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1982</year>;<volume>79</volume>(<issue>23</issue>):<fpage>7415</fpage>&#x02013;<lpage>9</lpage>. ; PubMed Central PMCID: PMCPMC347350.<?supplied-pmid 6296831?><pub-id pub-id-type="pmid">6296831</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Panicali</surname><given-names>D</given-names></name>, <name><surname>Paoletti</surname><given-names>E</given-names></name>. <article-title>Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1982</year>;<volume>79</volume>(<issue>16</issue>):<fpage>4927</fpage>&#x02013;<lpage>31</lpage>. ; PubMed Central PMCID: PMCPMC346798.<?supplied-pmid 6289324?><pub-id pub-id-type="pmid">6289324</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Joklik</surname><given-names>WK</given-names></name>, <name><surname>Woodroofe</surname><given-names>GM</given-names></name>, <name><surname>Holmes</surname><given-names>IH</given-names></name>, <name><surname>Fenner</surname><given-names>F</given-names></name>. <article-title>The reactivation of poxviruses. I. Demonstration of the phenomenon and techniques of assay</article-title>. <source>Virology</source>. <year>1960</year>;<volume>11</volume>:<fpage>168</fpage>&#x02013;<lpage>84</lpage>. .<?supplied-pmid 14407604?><pub-id pub-id-type="pmid">14407604</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Scheiflinger</surname><given-names>F</given-names></name>, <name><surname>Dorner</surname><given-names>F</given-names></name>, <name><surname>Falkner</surname><given-names>FG</given-names></name>. <article-title>Construction of chimeric vaccinia viruses by molecular cloning and packaging</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1992</year>;<volume>89</volume>(<issue>21</issue>):<fpage>9977</fpage>&#x02013;<lpage>81</lpage>. ; PubMed Central PMCID: PMCPMC50260.<?supplied-pmid 1438247?><pub-id pub-id-type="pmid">1438247</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Coley</surname><given-names>SE</given-names></name>, <name><surname>Lavi</surname><given-names>E</given-names></name>, <name><surname>Sawicki</surname><given-names>SG</given-names></name>, <name><surname>Fu</surname><given-names>L</given-names></name>, <name><surname>Schelle</surname><given-names>B</given-names></name>, <name><surname>Karl</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo</article-title>. <source>Journal of virology</source>. <year>2005</year>;<volume>79</volume>(<issue>5</issue>):<fpage>3097</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.79.5.3097-3106.2005</pub-id> ; PubMed Central PMCID: PMCPMC548458.<?supplied-pmid 15709029?><pub-id pub-id-type="pmid">15709029</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Merchlinsky</surname><given-names>M</given-names></name>, <name><surname>Moss</surname><given-names>B</given-names></name>. <article-title>Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors</article-title>. <source>Virology</source>. <year>1992</year>;<volume>190</volume>(<issue>1</issue>):<fpage>522</fpage>&#x02013;<lpage>6</lpage>. .<?supplied-pmid 1529553?><pub-id pub-id-type="pmid">1529553</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Domi</surname><given-names>A</given-names></name>, <name><surname>Moss</surname><given-names>B</given-names></name>. <article-title>Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>;<volume>99</volume>(<issue>19</issue>):<fpage>12415</fpage>&#x02013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.192420599</pub-id> ; PubMed Central PMCID: PMCPMC129459.<?supplied-pmid 12196634?><pub-id pub-id-type="pmid">12196634</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Wimmer</surname><given-names>E</given-names></name>, <name><surname>Mueller</surname><given-names>S</given-names></name>, <name><surname>Tumpey</surname><given-names>TM</given-names></name>, <name><surname>Taubenberger</surname><given-names>JK</given-names></name>. <article-title>Synthetic viruses: a new opportunity to understand and prevent viral disease</article-title>. <source>Nat Biotechnol</source>. <year>2009</year>;<volume>27</volume>(<issue>12</issue>):<fpage>1163</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1593</pub-id> ; PubMed Central PMCID: PMCPMC2819212.<?supplied-pmid 20010599?><pub-id pub-id-type="pmid">20010599</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Cello</surname><given-names>J</given-names></name>, <name><surname>Paul</surname><given-names>AV</given-names></name>, <name><surname>Wimmer</surname><given-names>E</given-names></name>. <article-title>Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template</article-title>. <source>Science</source>. <year>2002</year>;<volume>297</volume>(<issue>5583</issue>):<fpage>1016</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1072266</pub-id> .<?supplied-pmid 12114528?><pub-id pub-id-type="pmid">12114528</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Tumpey</surname><given-names>TM</given-names></name>, <name><surname>Basler</surname><given-names>CF</given-names></name>, <name><surname>Aguilar</surname><given-names>PV</given-names></name>, <name><surname>Zeng</surname><given-names>H</given-names></name>, <name><surname>Solorzano</surname><given-names>A</given-names></name>, <name><surname>Swayne</surname><given-names>DE</given-names></name>, <etal>et al</etal>
<article-title>Characterization of the reconstructed 1918 Spanish influenza pandemic virus</article-title>. <source>Science</source>. <year>2005</year>;<volume>310</volume>(<issue>5745</issue>):<fpage>77</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1126/science.1119392</pub-id> .<?supplied-pmid 16210530?><pub-id pub-id-type="pmid">16210530</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Becker</surname><given-names>MM</given-names></name>, <name><surname>Graham</surname><given-names>RL</given-names></name>, <name><surname>Donaldson</surname><given-names>EF</given-names></name>, <name><surname>Rockx</surname><given-names>B</given-names></name>, <name><surname>Sims</surname><given-names>AC</given-names></name>, <name><surname>Sheahan</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>;<volume>105</volume>(<issue>50</issue>):<fpage>19944</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0808116105</pub-id> ; PubMed Central PMCID: PMCPMC2588415.<?supplied-pmid 19036930?><pub-id pub-id-type="pmid">19036930</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Oldfield</surname><given-names>LM</given-names></name>, <name><surname>Grzesik</surname><given-names>P</given-names></name>, <name><surname>Voorhies</surname><given-names>AA</given-names></name>, <name><surname>Alperovich</surname><given-names>N</given-names></name>, <name><surname>MacMath</surname><given-names>D</given-names></name>, <name><surname>Najera</surname><given-names>CD</given-names></name>, <etal>et al</etal>
<article-title>Genome-wide engineering of an infectious clone of herpes simplex virus type 1 using synthetic genomics assembly methods</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2017</year>;<volume>114</volume>(<issue>42</issue>):<fpage>E8885</fpage>&#x02013;<lpage>E94</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1700534114</pub-id> ; PubMed Central PMCID: PMCPMC5651731.<?supplied-pmid 28928148?><pub-id pub-id-type="pmid">28928148</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Vashee</surname><given-names>S</given-names></name>, <name><surname>Stockwell</surname><given-names>TB</given-names></name>, <name><surname>Alperovich</surname><given-names>N</given-names></name>, <name><surname>Denisova</surname><given-names>EA</given-names></name>, <name><surname>Gibson</surname><given-names>DG</given-names></name>, <name><surname>Cady</surname><given-names>KC</given-names></name>, <etal>et al</etal>
<article-title>Cloning, Assembly, and Modification of the Primary Human Cytomegalovirus Isolate Toledo by Yeast-Based Transformation-Associated Recombination</article-title>. <source>mSphere</source>. <year>2017</year>;<volume>2</volume>(<issue>5</issue>). <pub-id pub-id-type="doi">10.1128/mSphereDirect.00331-17</pub-id> ; PubMed Central PMCID: PMCPMC5628293.<?supplied-pmid 28989973?><pub-id pub-id-type="pmid">28989973</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Lartigue</surname><given-names>C</given-names></name>, <name><surname>Vashee</surname><given-names>S</given-names></name>, <name><surname>Algire</surname><given-names>MA</given-names></name>, <name><surname>Chuang</surname><given-names>RY</given-names></name>, <name><surname>Benders</surname><given-names>GA</given-names></name>, <name><surname>Ma</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Creating bacterial strains from genomes that have been cloned and engineered in yeast</article-title>. <source>Science</source>. <year>2009</year>;<volume>325</volume>(<issue>5948</issue>):<fpage>1693</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.1173759</pub-id> .<?supplied-pmid 19696314?><pub-id pub-id-type="pmid">19696314</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Benders</surname><given-names>GA</given-names></name>, <name><surname>Noskov</surname><given-names>VN</given-names></name>, <name><surname>Denisova</surname><given-names>EA</given-names></name>, <name><surname>Lartigue</surname><given-names>C</given-names></name>, <name><surname>Gibson</surname><given-names>DG</given-names></name>, <name><surname>Assad-Garcia</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Cloning whole bacterial genomes in yeast</article-title>. <source>Nucleic Acids Res</source>. <year>2010</year>;<volume>38</volume>(<issue>8</issue>):<fpage>2558</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkq119</pub-id> ; PubMed Central PMCID: PMCPMC2860123.<?supplied-pmid 20211840?><pub-id pub-id-type="pmid">20211840</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Gibson</surname><given-names>DG</given-names></name>, <name><surname>Glass</surname><given-names>JI</given-names></name>, <name><surname>Lartigue</surname><given-names>C</given-names></name>, <name><surname>Noskov</surname><given-names>VN</given-names></name>, <name><surname>Chuang</surname><given-names>RY</given-names></name>, <name><surname>Algire</surname><given-names>MA</given-names></name>, <etal>et al</etal>
<article-title>Creation of a bacterial cell controlled by a chemically synthesized genome</article-title>. <source>Science</source>. <year>2010</year>;<volume>329</volume>(<issue>5987</issue>):<fpage>52</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1126/science.1190719</pub-id> .<?supplied-pmid 20488990?><pub-id pub-id-type="pmid">20488990</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Annaluru</surname><given-names>N</given-names></name>, <name><surname>Muller</surname><given-names>H</given-names></name>, <name><surname>Mitchell</surname><given-names>LA</given-names></name>, <name><surname>Ramalingam</surname><given-names>S</given-names></name>, <name><surname>Stracquadanio</surname><given-names>G</given-names></name>, <name><surname>Richardson</surname><given-names>SM</given-names></name>, <etal>et al</etal>
<article-title>Total synthesis of a functional designer eukaryotic chromosome</article-title>. <source>Science</source>. <year>2014</year>;<volume>344</volume>(<issue>6179</issue>):<fpage>55</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1126/science.1249252</pub-id> ; PubMed Central PMCID: PMCPMC4033833.<?supplied-pmid 24674868?><pub-id pub-id-type="pmid">24674868</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Richardson</surname><given-names>SM</given-names></name>, <name><surname>Mitchell</surname><given-names>LA</given-names></name>, <name><surname>Stracquadanio</surname><given-names>G</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Dymond</surname><given-names>JS</given-names></name>, <name><surname>DiCarlo</surname><given-names>JE</given-names></name>, <etal>et al</etal>
<article-title>Design of a synthetic yeast genome</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>):<fpage>1040</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1126/science.aaf4557</pub-id> .<?supplied-pmid 28280199?><pub-id pub-id-type="pmid">28280199</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Mitchell</surname><given-names>LA</given-names></name>, <name><surname>Wang</surname><given-names>A</given-names></name>, <name><surname>Stracquadanio</surname><given-names>G</given-names></name>, <name><surname>Kuang</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Synthesis, debugging, and effects of synthetic chromosome consolidation: synVI and beyond</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf4831</pub-id> .<?supplied-pmid 28280154?><pub-id pub-id-type="pmid">28280154</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Shen</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Chen</surname><given-names>T</given-names></name>, <name><surname>Gao</surname><given-names>F</given-names></name>, <name><surname>Gong</surname><given-names>J</given-names></name>, <name><surname>Abramczyk</surname><given-names>D</given-names></name>, <etal>et al</etal>
<article-title>Deep functional analysis of synII, a 770-kilobase synthetic yeast chromosome</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf4791</pub-id> ; PubMed Central PMCID: PMCPMC5390853.<?supplied-pmid 28280153?><pub-id pub-id-type="pmid">28280153</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>BZ</given-names></name>, <name><surname>Zhao</surname><given-names>M</given-names></name>, <name><surname>Mitchell</surname><given-names>LA</given-names></name>, <name><surname>Xie</surname><given-names>ZX</given-names></name>, <name><surname>Lin</surname><given-names>QH</given-names></name>, <etal>et al</etal>
<article-title>Bug mapping and fitness testing of chemically synthesized chromosome X</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf4706</pub-id> ; PubMed Central PMCID: PMCPMC5679077.<?supplied-pmid 28280152?><pub-id pub-id-type="pmid">28280152</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>ZX</given-names></name>, <name><surname>Li</surname><given-names>BZ</given-names></name>, <name><surname>Mitchell</surname><given-names>LA</given-names></name>, <name><surname>Wu</surname><given-names>Y</given-names></name>, <name><surname>Qi</surname><given-names>X</given-names></name>, <name><surname>Jin</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>"Perfect" designer chromosome V and behavior of a ring derivative</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf4704</pub-id> .<?supplied-pmid 28280151?><pub-id pub-id-type="pmid">28280151</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>W</given-names></name>, <name><surname>Zhao</surname><given-names>G</given-names></name>, <name><surname>Luo</surname><given-names>Z</given-names></name>, <name><surname>Lin</surname><given-names>Y</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Guo</surname><given-names>Y</given-names></name>, <etal>et al</etal>
<article-title>Engineering the ribosomal DNA in a megabase synthetic chromosome</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf3981</pub-id> .<?supplied-pmid 28280149?><pub-id pub-id-type="pmid">28280149</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Mercy</surname><given-names>G</given-names></name>, <name><surname>Mozziconacci</surname><given-names>J</given-names></name>, <name><surname>Scolari</surname><given-names>VF</given-names></name>, <name><surname>Yang</surname><given-names>K</given-names></name>, <name><surname>Zhao</surname><given-names>G</given-names></name>, <name><surname>Thierry</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>3D organization of synthetic and scrambled chromosomes</article-title>. <source>Science</source>. <year>2017</year>;<volume>355</volume>(<issue>6329</issue>). <pub-id pub-id-type="doi">10.1126/science.aaf4597</pub-id> ; PubMed Central PMCID: PMCPMC5679085.<?supplied-pmid 28280150?><pub-id pub-id-type="pmid">28280150</pub-id></mixed-citation></ref><ref id="ppat.1007019.ref035"><label>35</label><mixed-citation publication-type="book">Sciences SAoAa. Misuse potential and biosecurity in life sciences research. Swiss Academies Reports 2017.</mixed-citation></ref></ref-list></back></article>